| Name | Title | Contact Details |
|---|
Marina Care Ctr is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blueberry Pediatrics is a company that provides 24/7 on-demand pediatric care through a smartphone app, with $0 visits and home medical devices available.
Stemedica Cell Technologies, Inc., a biopharmaceutical company, engages in the development and manufacture of adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies. The company was incorporated in 2005 and is based in San Diego, California with a subsidiary location in Lausanne, Switzerland.
We bring many years of combined experience of equipment support, on-staff hospital imaging engineering and operations into a top-notch group of service and sales professionals. In-depth knowledge and customer focus is key. We handle all types of MRI and CT maintenance and services, including full system installation, rigging, de-installation, cold-head replacement and cryogen fills. These are just some of the reasons why leading hospitals and physician groups rely on East Coast Medical Systems to repair and service their imaging equipment.Our purpose is to express our diligence, knowledge and vigilance by pinpointing our customer`s needs and by addressing their problems, by hiring highly skilled engineers in order to provide an exact diagnosis and by being keenly watchful for any ensuing problems. To grow the organization properly, and maintain our reputation as being one of the highest regarded companies in our field, both by our customers and our peers.
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.